Manufacturing, Aseptic Processing

Apr 01, 2008
BioPharm International
A case study investigated the root cause of failures in sterile filtration by evaluating the effects and interactions of four operating parameters.
Mar 01, 2008
BioPharm International
By BioPharm International Editors
Need a standard to follow? Just ask, What would Genentech do?
Feb 01, 2008
BioPharm International
By BioPharm International Editors
Best practices from Big Biotech, including how to handle new product introductions.
Jul 24, 2007
BioPharm International
By BioPharm International Editors
The US Pharmacopeia (Rockville, MD, USP, www.usp.org) recently announced that the implementation period for its USP­–NF general notices statement requiring all manufacturers to conform to recently revised residual solvent standards in General Chapter <467> has been extended from July 1, 2007 to July 1, 2008.
May 01, 2007
BioPharm International
Membrane-based chromatography technologies sometimes offer advantages over resin-based technologies.
Apr 01, 2007
BioPharm International
By BioPharm International Editors
Although contaminants and other parameters may be main causes of filter breakdown, some nanofilters still remove viruses at high Log Reduction Value (LRV).
Jan 01, 2007
BioPharm International
By BioPharm International Editors
The HSV-1 and HVP-2 titers were determined by the inoculation of test solutions into Vero cell cultures and calculated using the Reed M?ench method.
Nov 29, 2006
BioPharm International
By BioPharm International Editors
NovAseptic mixers from Millipore (www.millipore.com/bioprocess) are designed for a variety of mixing applications in the pharmaceutical and biotechnology industries and are magnetically driven, which minimizes contamination risk.
native1_300x100
lorem ipsum